ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006

Yates Named DRCCA AD To Head Centers, CCOP, Organ Sites: CCOP Workshops Listed

February 26, 1982

Youth Smoking Linked To Exposure In Movies

December 30, 2005

Bunn To Succeed Norton As ASCO President, Tempero Is President-Elect

April 26, 2002